Ignyta’s $75M Offering

Coverage of Ignyta and its public offering of $75M: Ignyta holds $75M offering "Ignyta, a San Diego developer of cancer treatments, said Tuesday it is raising $75 million in a public stock offering. The biotech is developing drugs in tandem with diagnostics to find patients best suited to its therapies. The therapies target the genetics of cancer, [...]

June 10th, 2015|

Ambrx Acquisition Coverage

Coverage on the news of Ambrx being acquired: Chinese drugmakers snag antibody expert Ambrx in joint buyout "A group of Chinese biotech heavyweights are banding together to buy Ambrx, R&D partner to the likes of Bristol-Myers Squibb ($BMY) and Merck ($MRK), in hopes of making the company a go-to collaborator in their native country. Under the [...]

May 27th, 2015|

Sorrento Therapeutics’ Big Deal

From press release: "Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), announced today that NantPharma, founded by Dr. Patrick Soon-Shiong and a member of the NantWorks ecosystem of companies, agreed to acquire the rights to Cynviloq through the acquisition of Igdrasol, Inc., a wholly-owned subsidiary of Sorrento, which has been developing Cynviloq (paclitaxel nanoparticle polymeric micelle) in [...]

May 15th, 2015|

aTyr Pharma Raises Total Proceeds of $75M in IPO

Excerpt of story from Bruce V. Bigelow of Xconomy about aTyr Pharma pricing its IPO: "The offering raised gross proceeds of $75 million, and gives aTyr a fully diluted market value of $333 million, according to Renaissance Capital, a manager of IPO-based exchange traded funds. In a statement, aTyr said it also granted underwriters a 30-day option [...]

May 7th, 2015|

Biotech Dominates San Diego First-Quarter VC Funding

From Bruce V. Bigelow for Xconomy: "Venture funding for software staged a comeback in San Diego during the first quarter, with investments classified as software deals accounting for nearly $110 million, or 40 percent of the $270 million that venture firms invested in the San Diego area, according to the latest MoneyTree Report. Of 19 [...]

April 21st, 2015|

$3M California Initiative to Advance Precision Medicine

Coverage of The California Initiative to Advance Precision Medicine (aka the "Google maps for health"): Silicon Valley Business Journal: "By weaving together a hodgepodge of patient and clinical data, other important factors and scientific know-how, California officials hope to create a sort of "Google Maps for health" that will help deliver the right therapies to [...]

April 15th, 2015|

MabVax Catches Eye of Billionaire Investor

From press release: "Investors at MabVax Therapeutics (MBVX) must feel like they're in just the right place at just the right time this week as news of billionaire Bio-Pharma Investor Dr. Phillip Frost, M.D., and his company OPKO Health (OPK) have taken a strong interest in the clinical stage cancer immunotherapy company -- a $12 [...]

April 9th, 2015|

San Diego #2 in Digital Health Funding

StartUp Health has put out its Insights Report - Digital Health Funding Data 2015 Q1, and San Diego is #2 region as the "Big 3" lead the charge. The summary: "Coming off a hot funding environment in 2014, this year is off to a slower start. Although less capital was invested in Q1 2015 than in Q1 2014, we [...]

April 3rd, 2015|

Teva Buying Auspex Pharma for $3.2B

Additional coverage: FierceBiotech: "Three months after Auspex Pharmaceuticals ($ASPX) excited the market with news that its Phase III study of a new drug for controlling the involuntary movements triggered by Huntington's disease had succeeded, Teva has swooped in to buy the company in a deal that values the biotech at $3.2 billion. Teva is paying $101 [...]

March 30th, 2015|

UCSD’s Crowdfunding Site

From UT-San Diego: "UC San Diego has joined the floodtide of universities that have created their own online crowdfunding sites, a move that’s bringing in money for projects as different as electric car research and renovating a baseball park. The site, Crowdsurf, is getting underway at the same time that one of the school’s professors [...]

March 19th, 2015|

San Diego’s Rank in GEN’s Top 10 U.S. Biopharma Clusters List

"Ranking season" has begun. Generally in March, several media resources tally their data and information for the year to show the developments in various life science regions, and this year GEN starts off the "season" with its annual "Top 10 U.S. Biopharma Clusters" list - how did San Diego fare among the Big 3 and the rest [...]

March 9th, 2015|

Orexigen Surges, But…

From Bloomberg: "Orexigen Therapeutics Inc. shares soared to their highest value in more than 18 months after the drugmaker said its diet pill Contrave had cardiovascular benefits. Regulators and the study’s researchers criticized the drugmaker for releasing the data, saying it wasn’t meant to be public. Patients on Contrave had fewer major adverse cardiovascular events [...]

March 4th, 2015|

CIRM’s Klein Proposes $100B Biomed Program

From Bradley J Fikes at UT-San Diego: "Bob Klein, the main backer of California's 2004 stem cell initiative has proposed a $100 billion international bond program in life sciences, to speed up research and clinical testing of disease therapies. The program would be focused on stem cells and genomics. The United States and a few [...]

February 23rd, 2015|

What Motivates Prebys to Give $150M?

From UT-San Diego's feature on philanthropist Conrad Prebys: "Thus far Prebys — who made his money constructing, buying and running apartment complexes — has donated more than $150 million to an eclectic host of causes since 2007. Gifts such as the $45 million contribution that helped to build the heart institute and a recent $25 million commitment [...]

February 17th, 2015|

California’s $1 Billion Stem-Cell Renovation Show

From Alex Lash/Xconomy: "Home remodeling shows are a reality TV staple. But no Park Avenue mansion or country estate can top the nearly $1 billion price tag of the house C. Randal Mills is trying to renovate on the fly in California. Mills, who goes by Randy, is the president of the State of California’s [...]

February 8th, 2015|

Illumina Earnings Surge in 2014

From UT-San Diego's Bradley J. Fikes: "Illumina's net income and revenue soared in the fourth quarter of 2014, as the DNA sequencing giant continued to gain customers for its high-performance instruments. The San Diego company brought in $512 million revenue and $153 million net income for the quarter ended Dec. 31, the company announced. Revenue was $387 [...]

January 28th, 2015|

More on Qualcomm-Novartis Deal

From Xconomy: Qualcomm-Novartis Deal Portends Wave of Clinical Trial Innovation "After establishing a separate $100 million fund for healthtech startups in 2011, Qualcomm Ventures has made 21 investments and ranked as the biggest corporate venture investor in 2014, according to Rock Health. As an outgrowth of their new partnership, Qualcomm and Novartis also agreed to form [...]

January 20th, 2015|

Ansun Biopharma to Pay $2M For Grant Fraud

Coverage of Ansun Biopharma fraud case: UT-San Diego: San Diego biotech to pay $2M for grant fraud More San Diego Business Journal: Ansun Biopharma to Pay $2 Million to Settle Fraud Complaints More Company press release More

January 12th, 2015|

Best and Worst 2014 Biotech Performers on Wall Street

As a year-end recap, FierceBiotech takes a look at 2014's best and worst biotech performers on Wall Street, which include a few San Diego-area companies. An excerpt: "The biotechs on this list were selected only from those with a market capitalization of $300 million or more to avoid getting mired in the most volatile micro-caps. In addition, [...]

December 30th, 2014|

CIRM Speeds Up Funding Process

From the video caption: "The mission of CIRM, California's Stem Cell Agency, is to accelerate the development of stem cell treatments for patients with unmet medical needs. To that end, on December 11, 2014, the CIRM governing Board approved a $50 million concept plan called CIRM 2.0 which is a streamlined process that will make [...]

December 14th, 2014|